BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang C, Wei Y, Wang G, Zhou Y, Zhang J, Xu K. Heparanase potentiates the invasion and migration of pancreatic cancer cells via epithelial‑to‑mesenchymal transition through the Wnt/β‑catenin pathway. Oncol Rep 2020;44:711-21. [PMID: 32627022 DOI: 10.3892/or.2020.7641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Cousin R, Groult H, Manseur C, Ferru-Clément R, Gani M, Havret R, Toucheteau C, Prunier G, Colin B, Morel F, Piot JM, Lanneluc I, Baranger K, Maugard T, Fruitier-Arnaudin I. A Marine λ-Oligocarrageenan Inhibits Migratory and Invasive Ability of MDA-MB-231 Human Breast Cancer Cells through Actions on Heparanase Metabolism and MMP-14/MMP-2 Axis. Mar Drugs 2021;19:546. [PMID: 34677445 DOI: 10.3390/md19100546] [Reference Citation Analysis]
2 Zhi S, Li J, Kong X, Xie X, Zhang Q, Fang G. Insulin-like growth factor 2 mRNA binding protein 2 regulates proliferation, migration, and angiogenesis of keratinocytes by modulating heparanase stability. Bioengineered 2021;12:11267-76. [PMID: 34753397 DOI: 10.1080/21655979.2021.2002495] [Reference Citation Analysis]
3 De Pasquale V, Pavone LM. Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment. Int J Mol Sci 2020;21:E6588. [PMID: 32916872 DOI: 10.3390/ijms21186588] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
4 Jayatilleke KM, Hulett MD. Heparanase and the hallmarks of cancer. J Transl Med 2020;18:453. [PMID: 33256730 DOI: 10.1186/s12967-020-02624-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
5 Yang C, Zhang S, Chang X, Huang Y, Cui D, Liu Z. MicroRNA-219a-2-3p modulates the proliferation of thyroid cancer cells via the HPSE/cyclin D1 pathway. Exp Ther Med 2021;21:659. [PMID: 33968189 DOI: 10.3892/etm.2021.10091] [Reference Citation Analysis]